Inspire Medical Systems Inc [INSP] stock prices are up 0.59% to $76.82 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INSP shares have gain 3.53% over the last week, with a monthly amount drifted -8.06%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on September 22, 2025, when UBS downgraded its rating to a Neutral but kept the price target unchanged to $89 for it. Previously, Evercore ISI started tracking the stock with Outperform rating on September 02, 2025, and set its price target to $150. On August 05, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $125 on the stock. KeyBanc Capital Markets downgraded its rating to a Sector Weight. JP Morgan downgraded its rating to a Neutral but $110 remained the price target by the analyst firm on August 05, 2025. BofA Securities upgraded its rating to Buy for this stock on November 20, 2024, and upped its price target to $255. In a note dated May 08, 2024, BofA Securities downgraded an Neutral rating on this stock and revised its target price from $265 to $225.
The stock price of Inspire Medical Systems Inc [INSP] has been fluctuating between $70.77 and $216.01 over the past year. Currently, Wall Street analysts expect the stock to reach $152.38 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $76.82 at the most recent close of the market. An investor can expect a potential return of 98.36% based on the average INSP price forecast.
Analyzing the INSP fundamentals
The Inspire Medical Systems Inc [NYSE:INSP] reported sales of 861.31M for trailing twelve months, representing a surge of 10.82% . Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.08 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 75.91 points at the first support level, and at 75.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 77.71, and for the 2nd resistance point, it is at 78.61.
Ratios To Look Out For
It’s worth pointing out that Inspire Medical Systems Inc [NYSE:INSP]’s Current Ratio is 6.14. As well, the Quick Ratio is 4.84, while the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 2.64, the price to book ratio is 3.35 and price to earnings (TTM) ratio is 44.50.
Transactions by insiders
Recent insider trading involved Buchholz Richard, Chief Financial Officer, that happened on Aug 29 ’25 when 11000.0 shares were sold. Officer, Buchholz Richard completed a deal on Aug 29 ’25 to buy 11000.0 shares. Meanwhile, Rondoni John sold 1734.0 shares on May 19 ’25.
